Icecure Medical is trading 5.10% up at $1.65 in after-hours trading, with no clear company-specific catalyst identified. - The stock closed at $1.57 on October 2, 2026. - Its latest listed press release was September 10, announcing Chinese regulatory approval for ProSense; the official release page shows no October 2 announcement. - Broad indexes gained during the session, but that does not establish a reason for the after-hours move.